Technological advancements, increase in applications of DNA sequencing, rise in collaborations & partnerships
WILMINGTON, DELAWARE, UNITED STATES, July 12, 2024 /
EINPresswire.com/ --
DNA sequencing market generated $9.05 billion in 2019, and is estimated to reach USD 25.47 billion by 2025, growing at a CAGR of 19.0% from 2018 to 2025.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭:
https://www.alliedmarketresearch.com/request-sample/163
Technological advancements, increase in applications of DNA sequencing, rise in collaborations & partnerships, and rise in genome mapping programs drive the growth of the global DNA sequencing market. However, scarcity of skilled professionals and concerns related to standardization of DNA sequencing-based diagnostics hinder the market growth. On the other hand, acceptance of cloud computing as potential data management service along with untapped potential in emerging economies create new opportunities.
Based on product, the consumables segment accounted for the highest market share in 2018, holding more than half of the global DNA sequencing market. This segment is estimated to maintain its dominant share during the forecast period. However, the platforms segment is expected to register at the highest CAGR of 22.0% from 2018 to 2025. The research also analyzes the services segment.
Based on application, the biomarkers and cancer segment contributed to the highest share in 2018, accounting for more than one-third of the market. However, the personalized medicine segment is expected to register the fastest CAGR of 26.7% from 2018 to 2025.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲 𝐚𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/163
Based on technology, the sequencing by synthesis segment accounted for the largest share in 2018, accounting for more than one-fifth of the market, and is expected to maintain its dominance during the forecast period. However, the pyrosequencing segment is estimated to portray the highest CAGR of 27.2% during the forecast period.
On the basis of region, North America held more than two-fifths of the global DNA sequencing market and is estimated to maintain its lead position throughout the forecast period. However, Asia-Pacific is expected to witness the highest CAGR of 24.1% during the forecast period.
𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚
(U.S., Canada, Mexico)
𝐄𝐮𝐫𝐨𝐩𝐞
(Germany, France, UK, Italy, Spain, Rest of Europe)
𝐀𝐬𝐢𝐚-𝐏𝐚𝐜𝐢𝐟𝐢𝐜
(Japan, China, India, Rest of Asia-Pacific)
𝐋𝐀𝐌𝐄𝐀
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬 𝐚𝐧𝐚𝐥𝐲𝐳𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭
Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), Agilent Technologies, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Pacific Biosciences of California, Inc., LI-COR Biosciences, Inc., PerkinElmer Inc., Siemens AG, and Thermo Fisher Scientific, Inc.
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter